Sanofi-Aventis To Work With Chinese Experts In Cancer Stem-Cell Research
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Sanofi-Aventis will expand its footprint in China by collaborating with Tianjin's Institute of Hematology and Blood Diseases Hospital (IHBDH) in the field of cancer stem cells, the French drug maker announced Sept. 14